Core Scientific (CORZ) Net Equity Issued and Repurchased (2021 - 2024)

Core Scientific has disclosed Net Equity Issued and Repurchased across 3 years of filings, most recently posting $55.0 million for Q1 2024.

• In Q1 2024, Net Equity Issued and Repurchased changed N/A year-over-year to $55.0 million; the TTM figure through Dec 2024 stood at $55.0 million (changed N/A YoY), while the FY2024 annual figure was $55.0 million, changed N/A from the prior year.
• Net Equity Issued and Repurchased came in at $55.0 million for Q1 2024 at Core Scientific, up from -$198.9 million in the prior quarter.
• In the past five years, Net Equity Issued and Repurchased ranged from a high of $195.0 million in Q1 2022 to a low of -$198.9 million in Q3 2022.
• Average Net Equity Issued and Repurchased over 3 years is $11.1 million, with a median of $3.8 million recorded in 2022.
• The largest YoY upside for Net Equity Issued and Repurchased was 39216.53% in 2022 against a maximum downside of 39216.53% in 2022.
• Over 3 years, Net Equity Issued and Repurchased stood at $496000.0 in 2021, then plunged by 40192.14% to -$198.9 million in 2022, then surged by 127.66% to $55.0 million in 2024.
• Per Business Quant data, the three most recent Net Equity Issued and Repurchased figures were $55.0 million in Q1 2024, -$198.9 million in Q3 2022, and $3.8 million in Q2 2022.